VERACYTE, INC. Proceeds from Long-Term Debt Issued
VERACYTE, INC. (VCYT) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2020-02-25
- VERACYTE, INC. proceeds from issuance of long-term debt for the quarter ending 2017-12-31 was $24.88M.
- VERACYTE, INC. proceeds from issuance of long-term debt for the quarter ending 2017-09-30 was $0.00.
- VERACYTE, INC. proceeds from issuance of long-term debt for the quarter ending 2017-06-30 was $0.00.
- VERACYTE, INC. proceeds from issuance of long-term debt for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- VERACYTE, INC. proceeds from issuance of long-term debt for fiscal 2019 was $0.00.
- VERACYTE, INC. proceeds from issuance of long-term debt for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- VERACYTE, INC. proceeds from issuance of long-term debt for fiscal 2017 was $24.88M, a 1.75% increase from fiscal 2016.
- VERACYTE, INC. proceeds from issuance of long-term debt for fiscal 2016 was $24.45M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-25 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-25 | |||
| 2017-12-31 | $24.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $24.88M derived: sum of 2 quarters · filed 2020-02-25 | $24.88M derived: sum of 3 quarters · filed 2020-02-25 | $24.88M 10-K · filed 2020-02-25 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $0.00 10-Q · filed 2017-07-31 | $0.00 derived: sum of 3 quarters · filed 2019-02-25 | $0.00 derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-03 | $0.00 derived: sum of 2 quarters · filed 2019-02-25 | $0.00 derived: sum of 3 quarters · filed 2019-02-25 | -$148.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $0.00 derived: sum of 2 quarters · filed 2019-02-25 | -$148.00K derived: sum of 3 quarters · filed 2019-02-25 | $24.45M 10-K · filed 2019-02-25 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$148.00K derived: sum of 2 quarters · filed 2017-11-07 | $24.45M 10-Q · filed 2017-11-07 | $24.45M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $24.45M 10-Q · filed 2017-07-31 | $24.45M derived: sum of 3 quarters · filed 2018-02-27 | $24.45M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $24.60M 10-Q · filed 2017-05-03 | $24.60M derived: sum of 2 quarters · filed 2018-02-27 | $24.60M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-03 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | $4.88M 10-K · filed 2016-03-14 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $4.88M 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $4.88M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |